Martin Allan

Title: Martin Allan: Innovator in Protein Arginine Methyltransferase Inhibition

Introduction

Martin Allan is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of biochemistry, particularly in the development of small molecule inhibitors. His work focuses on compounds that target protein arginine methyltransferases, which play a crucial role in various biological processes.

Latest Patents

Martin Allan holds a patent for his invention titled "Amines as small molecule inhibitors." This patent relates to compounds that are effective as inhibitors of protein arginine methyltransferase. The compounds are defined by specific formulas and include racemic mixtures, diastereomers, enantiomers, and tautomers, along with their N-oxides, hydrates, solvates, pharmaceutically acceptable salts, prodrugs, and complexes. The invention also encompasses compositions that include these compounds and methods for their application.

Career Highlights

Throughout his career, Martin has been associated with Methylgene, Inc., where he has contributed to innovative research and development. His expertise in biochemistry and pharmacology has positioned him as a key player in the field of drug discovery and development.

Collaborations

Martin Allan has collaborated with several professionals in his field, including Sukhdev Manku and Amal Wahhab. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Martin Allan's work in developing inhibitors for protein arginine methyltransferases showcases his dedication to advancing biochemistry. His contributions are significant in the realm of drug development, and his patent reflects the potential for new therapeutic approaches.